Your browser doesn't support javascript.
loading
Drug delivery based on chitosan, ß-cyclodextrin and sodium carboxymethyl cellulose as well as nanocarriers for advanced leukemia treatment.
Hosseini, Melika; Amiri, Mahnaz; Ghanbari, Mojgan; Mahdi, Makarim A; Abdulsahib, Waleed K; Salavati-Niasari, Masoud.
Afiliación
  • Hosseini M; Department of Chemistry, School of Physics and Chemistry, Alzahra University, Vanak, Tehran, Iran.
  • Amiri M; Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Science, Kerman, Iran; Department of Hematology and Laboratory Sciences, Faculty of Allied Medical Sciences, Kerman University of Medical Sciences, Kerman, Iran. Electronic address: ma.amiri@kmu.ac.ir.
  • Ghanbari M; Institute of Nano Science and Nano Technology, University of Kashan, P.O. Box 87317-51167, Kashan, Iran.
  • Mahdi MA; Department of Chemistry, College of Education, University of Al-Qadisiyah, Diwaniya, Iraq.
  • Abdulsahib WK; Department of Pharmacology and Toxicology, College of Pharmacy, Al-Farahidi University, Baghdad, Iraq.
  • Salavati-Niasari M; Institute of Nano Science and Nano Technology, University of Kashan, P.O. Box 87317-51167, Kashan, Iran. Electronic address: salavati@kashanu.ac.ir.
Biomed Pharmacother ; 153: 113369, 2022 Sep.
Article en En | MEDLINE | ID: mdl-35780615
ABSTRACT
Medicine/nanotechnology as a new and applicable technique according to drug delivery systems has gained great consideration for cancer treatment. Polysaccharides including, cellulose, ß-cyclodextrin and sodium carboxymethyl cellulose and chitosan as natural bio-materials, are appropriate candidates for designing and formulations of these nanosystems because of the exceptional advantages such as bio-compatibility, bio-degradability, non-toxicity, and gelling characteristics. An intelligent drug delivery platform based on these hybrids nowadays is developed, which can be used for dual-responsive dual-drug delivery. Nanotechnology accompany with biological molecules has been carefully considered to decrease the drawbacks of conventional cancer treatments. Consequently, this review is intended to state and investigate on the latest development on the combination treatment of platforms based on the hybrids of anticancer drugs/nanoparticles/Polysaccharides in the fields of biomedical therapeutics and cancer therapy owing to the bio-compatibility, great surface area, good chemical and mechanical features, the challenges and future perspectives are reported as well.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia / Beta-Ciclodextrinas / Quitosano / Nanopartículas Idioma: En Revista: Biomed Pharmacother Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Leucemia / Beta-Ciclodextrinas / Quitosano / Nanopartículas Idioma: En Revista: Biomed Pharmacother Año: 2022 Tipo del documento: Article